HomePoliticalHigh Court Overturns New Zealand’s Puberty Blocker Ban for Trans Youth

High Court Overturns New Zealand’s Puberty Blocker Ban for Trans Youth

The High Court has ruled that New Zealand’s ban on new puberty blocker prescriptions for transgender young people was unlawful. Justice Dale La Hood concluded that the regulations should be set aside. He delivered the judgment in Wellington on Wednesday, 21 October.

The Professional Association for Transgender Health Aotearoa (PATHA) brought the challenge. It says doctors can now prescribe the medicine as before. Times of Georgia found no Government statement on an appeal at the time of writing.

What the court found

Justice La Hood upheld two of PATHA’s grounds.

Consultation. The judge found that officials did not properly consult those affected. Those consulted would not have understood that the Government might ban new prescriptions, he said. “A prohibition on new prescriptions was a far more serious and concerning step than anything that had been proposed,” the judgment states. Gender-diverse young people and their families were not consulted properly. No strong timing reason justified that.

Discrimination. The Minister accepted that gender dysphoria and gender incongruence count as disabilities under the Human Rights Act. The judge found a rational basis for some restrictions. He held, however, that a complete ban was disproportionate. “The indefinite prohibition was an unjustifiable limit on the right to freedom from discrimination,” he wrote. He noted that the affected group faces a high risk of self-harm and suicide.

What the court did not decide

The ruling did not endorse every PATHA argument. Justice La Hood rejected two of them.

The judge dismissed the claim that Cabinet, not the Health Minister, made the decision. Health Minister Simeon Brown told the court he decided himself, and the judge accepted that. A second claim also failed: that the Minister acted for an improper purpose. Given the UK’s Cass Review, the judge found a rational basis for the Minister’s different view from his officials.

Nor did the court settle the medical debate. “It is neither possible nor appropriate for me to attempt to resolve the differences in expert opinion,” he said. He left other rights claims, including those on life and cruel treatment, for a future case.

PATHA also argued that the ban discriminated on the basis of sex. Times of Georgia could not confirm a finding on that point from the material reviewed.

What PATHA says

PATHA called the ruling a relief. “We’re incredibly relieved that the Court has come to this finding,” said president Jennifer Shields. She said restrictions on transgender healthcare have a major effect on health and wellbeing.

Dr Elizabeth McElrea, a GP and PATHA vice-president, said the ruling puts the decision “back in the consult room”. Clinicians can now prescribe “in line with best practice and without fear of retribution”, she said.

Secretary Avery Zavoda acknowledged the harm caused while families waited for the judgment. “Such an act of discrimination is something no young person should have to experience,” Zavoda said.

How the ban unfolded

DateDevelopment
19 November 2025The Government announces it will restrict new puberty blocker prescriptions for gender dysphoria.
Early December 2025PATHA files for judicial review.
17 December 2025The High Court orders the Crown not to enforce the regulations until the review ends.
19 December 2025The ban was due to take effect.
July 2026The case is set down for a three-day hearing before Justice La Hood.
21 October 2026The court rules the ban unlawful.

The Government’s case

Mr Brown defended the ban as a precaution. Cabinet decided “to align our approach with the UK”, he said when he announced it. He said the aim was “stronger safeguards so families could have confidence”.

A 2024 Ministry of Health evidence brief found “significant limitations in the quality of evidence” on puberty blockers for gender dysphoria. Ministers said they would wait for a UK clinical trial, with results not expected until 2031.

Under the ban, only new prescriptions were restricted. Young people already on treatment could continue. The medicines stay available for conditions such as early puberty, endometriosis and prostate cancer.

PATHA’s lawyer, Victoria Casey KC, told the court the decision was political. She pointed to a press release from Associate Health Minister Casey Costello. It began: “Today sanity won another battle on the war on woke.” Even so, the judge found no improper purpose in the Minister’s own decision.

What happens next

The Government may appeal. Times of Georgia found no response from Mr Brown or the Ministry of Health at the time of writing. Clinical support, including psychological support, was available to young people throughout the ban.

Families who need support can call or text 1737, the free national helpline, at any time. Youthline is on 0800 376 633.

An election-week backdrop

The ruling arrives 17 days before New Zealand’s 7 November general election. Our political coverage tracks the campaign. Recent reports include a pre-election debate planned by Waikato students and the Electoral Commission’s voter education campaign.

Based on a statement from PATHA and the High Court’s judgment, with information from Law News, Gay Express, PinkNews and the Ministry of Health. Times of Georgia publishes statements from advocacy groups for information and does not endorse any party or position.

- Advertisment -
Times of Georgia

Most Popular